MarketCap
Facebook
X
Telegram
Graybug Vision Langfristiger Schuldenstrom | GRAY
Langfristiger Schuldenstrom Jährlich Graybug Vision
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 203 K | - | - | - | - | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 203 K | 203 K | 203 K |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Crinetics Pharmaceuticals
CRNX
|
6.49 M | $ 84.95 | 0.13 % | $ 7.99 B |  USA |
 |
TFF Pharmaceuticals
TFFP
|
83.5 K | - | -60.05 % | $ 125 K | USA |
 |
Mesoblast Limited
MESO
|
2.68 M | $ 14.0 | -3.06 % | $ 16.9 B |  Australia |
 |
CorMedix
CRMD
|
853 K | $ 5.37 | -2.1 % | $ 387 K | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
4.71 M | - | -15.15 % | $ 60.3 M |  Britain |
 |
MannKind Corporation
MNKD
|
2.11 M | $ 4.22 | 0.84 % | $ 1.29 B | USA |
 |
AVEO Pharmaceuticals
AVEO
|
11 K | - | - | $ 521 M | USA |
 |
MediciNova
MNOV
|
194 K | $ 1.4 | -4.76 % | $ 68.7 M | USA |
 |
Merck & Co.
MRK
|
294 M | $ 147.75 | -0.68 % | $ 370 B | USA |
 |
Moderna
MRNA
|
17 M | $ 250.79 | -6.77 % | $ 97.6 B | USA |
 |
Axcella Health
AXLA
|
1.59 M | - | -16.42 % | $ 249 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
4.18 M | - | - | $ 2.02 B | USA |
 |
Intellia Therapeutics
NTLA
|
26.5 M | $ 11.18 | -7.72 % | $ 1.21 B | USA |
 |
Novartis AG
NVS
|
263 M | $ 163.39 | -0.18 % | $ 317 B |  Schweiz |
 |
Omeros Corporation
OMER
|
5.8 M | $ 17.3 | -1.48 % | $ 1.1 B | USA |
 |
Oramed Pharmaceuticals
ORMP
|
285 K | $ 3.97 | -0.75 % | $ 164 M |  Israel |
 |
Tyme Technologies
TYME
|
37.3 K | - | 8.07 % | $ 54 M | USA |
 |
Puma Biotechnology
PBYI
|
1.31 M | $ 8.13 | -3.22 % | $ 407 M | USA |
 |
PDS Biotechnology Corporation
PDSB
|
231 K | $ 1.02 | -5.09 % | $ 47.3 M | USA |
 |
Cyclerion Therapeutics
CYCN
|
3.29 M | $ 34.99 | 3.77 % | $ 147 M | USA |
 |
Pfizer
PFE
|
330 M | $ 29.34 | 0.36 % | $ 167 B | USA |
 |
PainReform Ltd.
PRFX
|
21 K | $ 0.78 | -4.24 % | $ 505 K | Israel |
 |
Prothena Corporation plc
PRTA
|
2.89 M | $ 8.56 | -2.51 % | $ 461 M | USA |
 |
Arcus Biosciences
RCUS
|
13 M | $ 18.66 | -1.56 % | $ 2 B | USA |
 |
Orgenesis
ORGS
|
234 K | - | -33.86 % | $ 61.2 M | USA |
 |
Regeneron Pharmaceuticals
REGN
|
37.8 M | $ 916.16 | -0.41 % | $ 95.8 B | USA |
 |
Replimune Group
REPL
|
1.16 M | $ 23.3 | 4.67 % | $ 2.16 B | USA |
 |
Royalty Pharma plc
RPRX
|
380 M | $ 69.47 | 1.02 % | $ 29.9 B | USA |
 |
Revolution Medicines
RVMD
|
16.5 M | $ 193.0 | -3.57 % | $ 36.7 B | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
650 K | $ 113.99 | 0.04 % | $ 7.41 B | USA |
 |
Codiak BioSciences
CDAK
|
2.66 M | - | -55.98 % | $ 2.15 M | USA |
 |
Sana Biotechnology
SANA
|
14.9 M | $ 2.43 | -1.42 % | $ 615 M | USA |
 |
Sol-Gel Technologies Ltd.
SLGL
|
495 K | $ 61.81 | 0.11 % | $ 172 M | Israel |
 |
Summit Therapeutics
SMMT
|
3.39 M | $ 17.78 | -0.34 % | $ 13.3 B | Britain |
 |
Syndax Pharmaceuticals
SNDX
|
470 K | $ 9.43 | -0.89 % | $ 817 M | USA |
 |
Spero Therapeutics
SPRO
|
1.96 M | $ 1.01 | -5.61 % | $ 56.6 M | USA |
 |
Sarepta Therapeutics
SRPT
|
11.2 M | $ 16.4 | -5.54 % | $ 1.64 B | USA |
 |
Tarsus Pharmaceuticals
TARS
|
608 K | $ 73.9 | 4.32 % | $ 3.09 B | USA |
 |
Bio-Techne Corporation
TECH
|
14.9 M | $ 72.83 | -0.01 % | $ 11.4 B | USA |
 |
Sage Therapeutics
SAGE
|
1.32 M | - | - | $ 527 M | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
1.95 M | - | - | $ 1.62 B | Israel |
 |
Cabaletta Bio
CABA
|
3.46 M | $ 1.43 | -5.0 % | $ 144 M | USA |
 |
Forma Therapeutics Holdings
FMTX
|
5.12 M | - | - | $ 958 M | USA |
 |
Blueprint Medicines Corporation
BPMC
|
13.3 M | - | - | $ 8.14 B | USA |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
7.8 M | - | - | $ 26.6 B |  Irlanda |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
125 K | $ 4.12 | -8.35 % | $ 35.1 M | USA |